ARIN ELSBERRY: Open Payments
NPI 1912538893 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 35 payments from 16 companies in 2025. Trend: 2023 $957 · 2024 $1,314 · 2025 $705
Food & beverage: $705
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $141 |
| Novo Nordisk Inc | 6 | $111 |
| ABBVIE INC. | 5 | $103 |
| PFIZER INC. | 5 | $84 |
| Boston Scientific Corporation | 1 | $35 |
| Astellas Pharma US Inc | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| Radius Health, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Seqirus USA Inc | 1 | $23 |
Products named: AIRSUPRA, VRAYLAR, Wegovy, NURTEC ODT, General - Pain Management, Veozah, REXULTI, LEQVIO.
Industry payments across NE — which companies pay providers there.
